CIHR HIV/AIDS Research Advisory Committee (CHARAC)

Background

The CIHR Institute of Infection and Immunity identified HIV/AIDS as one of its priority research areas and is committed to leading a process which will enable CIHR to systematically examine and act on HIV/AIDS research priorities. Upon consultation with various stakeholders, it was suggested that such a process would ideally be led by a group with in depth knowledge of all aspects of Canadian HIV/AIDS research, an understanding of the complex dynamics of the HIV/AIDS community, an ability to make recommendations on research policies and programs that would be supported by all of CIHR, and a capacity to act as a champion for HIV/AIDS researchers and individuals living with and vulnerable to HIV/AIDS.

CHARAC is an advisory committee for the CIHR HIV/AIDS Research Initiative. To ensure the appropriate expertise and knowledge is available to the Committee, CHARAC is composed of researchers and other representatives from across the full spectrum of HIV/ AIDS research and other relevant theme areas in Canada.

Committee Mandate and Structure

The Committee has a mandate to guide the implementation of the CIHR HIV/AIDS Research Initiative in keeping with parameters set out by the Federal Initiative to Address HIV AIDS in Canada. CHARAC advises the Scientific Director of the CIHR Institute of Infection and Immunity (III) and the CIHR Director General, Science Strategies and Initiatives, regarding research programs and priorities on HIV/AIDS. CHARAC is instrumental in providing guidance to the CIHR HIV/AIDS Research Initiative in the development and implementation of its strategic plan and in fulfilling responsibilities to the Federal Initiative to Address HIV/AIDS in Canada.

CHARAC reports, via the CIHR Institute of Infection and Immunity Scientific Director and the Director Genereal, Science Strategies and Initiatives, to the CIHR Science Council. This reporting ensures that the work of CHARAC has an impact which spans all 13 CIHR institutes.

The current membership of the CIHR HIV/AIDS Research Advisory Committee is as follows:

Jonathan Angel, Chair
Senior Scientist
Ottawa Hospital Research Institute

Marni Amirault
Community-Based Research Manager
Canadian Aboriginal AIDS Network

Chris Archibald
Director, Surveillance and Epidemiology Division
Centre for Communicable Diseases and Infection Control
Public Health Agency of Canada

Andrés Finzi
Assistant Professor and Canada Research Chair on Retroviral Entry
Centre de recherche de CHUM (CRCHUM)
Université de Montréal

Keith Fowke
Head
Department of Medical Microbiology
University of Manitoba

Trevor Hart
Professor
Department of Psychology
Ryerson University

Alexandra King
General Internist with HIV/HCV focus
Lu'ma Medical Centre

Joanne Lindsay
Board member
Ontario AIDS Network (OAN)

Paul MacPherson
Clinician Scientist
Ottawa Hospital Research Institute

David Moore
Research Scientist
BC Centre for Excellence in HIV/AIDS
St. Paul's Hospital

Marc Ouellette
Scientific Director
Institute of Infection and Immunity
Canadian Institutes of Health Research

Tim Rogers
Director of Knowledge Exchange
CATIE

Kate Shannon
Director of the Gender and Sexual Health Initiative
BC Center for Excellence in HIV/AIDS
St. Paul’s Hospital

Cécile Tremblay
Professor
Department of Microbiology, Immunology, and Infectious Diseases
University of Montreal

Date modified: